logo-loader
viewChipotle Mexican Grill

Chipotle slumps ahead of Wednesday’s open after quarterly results disappoint

“Despite several unusual impacts during the quarter, including the impact of hurricanes, we maintained our focus and saw some encouraging signs."

Chipotle Mexican Grill
Chipotle shares slumped 11.5% in premarket transactions

Investors are set to be burnt by Chipotle Mexican Grill Inc’s (NYSE:CMG) worse than expected results as Wall Street opens on Wednesday.

In pre-market deals the Mexican restaurant group’s stock was down US$37.30 or around 11.5% changing hands at US$287, meanwhile, Wall Street brokers started the day with some early morning downgrades.

JP Morgan dropped its target price to US$315 per share, from US$380, whereas Stifel Nicolaus moved its bar down to US$310 from US$345.

Chipotle reported a disappointing third quarter with a release after hours on Tuesday, with earnings stated at US$1.33 versus market expectations for US$1.63 per share. The quarter’s revenue was reported at US$1.13bn which was below the US$1.14bn market consensus.

“We continued to make important progress to improve the guest experience at our restaurants during the quarter,” said Steve Ells, Chipotle chief executive.

He added: “Despite several unusual impacts during the quarter, including the impact of hurricanes, we maintained our focus and saw some encouraging signs.

“Our leadership remains focused on setting the foundation for future growth, and we are confident in our teams’ ability to deliver against those plans.”

Quick facts: Chipotle Mexican Grill

Price: 754.66 USD

NYSE:CMG
Market: NYSE
Market Cap: $20.98 billion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Preveceutical announces successful preliminary evaluation of...

Preveceutical (CSE:PREV-OTCQB: PRVCF) President Mak Jawadeker joined Steve Darling from Proactive Vancouver on Skype to discuss the company successfully completing the design, synthesis and preliminary evaluation of key peptides from its scorpion venom-derived peptide research and development...

3 hours, 32 minutes ago

2 min read